Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease

Author： Malayandi Rajkumar   Kondamudi Phani   Ruby P.   Aggarwal Deepika  

Publisher： Springer Publishing Company

ISSN： 2190-393X

Source： Drug Delivery and Translational Research, Vol.4, Iss.2, 2014-04, pp. : 187-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD)

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 15, Iss. 2, 2016-12 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 5, 2013-10 ,pp. : 328-340

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Colon Specific Microspheres of Flurbiprofen for Inflammatory Bowel Disease

By  

Current Drug Delivery, Vol. 10, Iss. 5, 2013-10 ,pp. : 564-571

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

By Schwab M.   Klotz U.  

Clinical Pharmacokinetics, Vol. 40, Iss. 10, 2001-01 ,pp. : 723-751

Adis International

Access to resources Recommend Favorite

Imaging of the Colon in Inflammatory Bowel Disease: Ready for Prime Time?

By  

Current Drug Targets, Vol. 13, Iss. 10, 2012-09 ,pp. : 1252-1260

Bentham Science Publishers

Access to resources Recommend Favorite